24121116|t|Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse.
24121116|a|Parkinson's disease (PD) is a neurodegenerative disorder classically characterized by the death of dopamine (DA) neurons in the substantia nigra pars compacta and by intracellular Lewy bodies composed largely of alpha-synuclein. Approximately 5-10% of PD patients have a familial form of Parkinsonism, including mutations in alpha-synuclein. To better understand the cell-type specific role of alpha-synuclein on DA neurotransmission, and the effects of the disease-associated A30P mutation, we generated and studied a novel transgenic model of PD. We expressed the A30P mutant form of human alpha-synuclein in a spatially-relevant manner from the 111kb SNCA genomic DNA locus on a bacterial artificial chromosome (BAC) insert on a mouse null (Snca-/-) background. The BAC transgenic mice expressed alpha-synuclein in tyrosine hydroxylase-positive neurons and expression of either A30P alpha-synuclein or wildtype alpha-synuclein restored the sensitivity of DA neurons to MPTP in resistant Snca-/- animals. A30P alpha-synuclein mice showed no Lewy body-like aggregation, and did not lose catecholamine neurons in substantia nigra or locus coeruleus. However, using cyclic voltammetry at carbon-fiber microelectrodes we identified a deficit in evoked DA release in the caudate putamen, but not in the nucleus accumbens, of SNCA-A30P Snca-/- mice but no changes to release of another catecholamine, norepinephrine (NE), in the NE-rich ventral bed nucleus of stria terminalis. SNCA-A30P Snca-/- mice had no overt behavioral impairments but exhibited a mild increase in wheel-running. In summary, this refined PD mouse model shows that A30P alpha-synuclein preferentially perturbs the dopaminergic system in the dorsal striatum, reflecting the region-specific change seen in PD. 
24121116	28	36	dopamine	Chemical	MESH:D004298
24121116	46	60	norepinephrine	Chemical	MESH:D009638
24121116	83	87	A30P	ProteinMutation	tmVar:p|SUB|A|30|P;HGVS:p.A30P;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893878;CorrespondingSpecies:10090;CA#:257069
24121116	88	103	alpha-synuclein	Gene	6622
24121116	119	124	mouse	Species	10090
24121116	126	145	Parkinson's disease	Disease	MESH:D010300
24121116	147	149	PD	Disease	MESH:D010300
24121116	156	182	neurodegenerative disorder	Disease	MESH:D019636
24121116	225	233	dopamine	Chemical	MESH:D004298
24121116	235	237	DA	Chemical	MESH:D004298
24121116	311	317	bodies	Disease	MESH:D001835
24121116	338	353	alpha-synuclein	Gene	6622
24121116	378	380	PD	Disease	MESH:D010300
24121116	381	389	patients	Species	9606
24121116	414	426	Parkinsonism	Disease	MESH:D010302
24121116	451	466	alpha-synuclein	Gene	6622
24121116	520	535	alpha-synuclein	Gene	20617
24121116	539	541	DA	Chemical	MESH:D004298
24121116	603	607	A30P	ProteinMutation	tmVar:p|SUB|A|30|P;HGVS:p.A30P;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893878;CorrespondingSpecies:10090;CA#:257069
24121116	671	673	PD	Disease	MESH:D010300
24121116	692	696	A30P	ProteinMutation	tmVar:p|SUB|A|30|P;HGVS:p.A30P;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893878;CorrespondingSpecies:10090;CA#:257069
24121116	712	717	human	Species	9606
24121116	718	733	alpha-synuclein	Gene	6622
24121116	780	784	SNCA	Gene	20617
24121116	858	863	mouse	Species	10090
24121116	870	874	Snca	Gene	20617
24121116	910	914	mice	Species	10090
24121116	925	940	alpha-synuclein	Gene	20617
24121116	944	964	tyrosine hydroxylase	Gene	21823
24121116	1007	1011	A30P	ProteinMutation	tmVar:p|SUB|A|30|P;HGVS:p.A30P;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893878;CorrespondingSpecies:10090;CA#:257069
24121116	1012	1027	alpha-synuclein	Gene	6622
24121116	1040	1055	alpha-synuclein	Gene	6622
24121116	1084	1086	DA	Chemical	MESH:D004298
24121116	1098	1102	MPTP	Chemical	MESH:D015632
24121116	1116	1120	Snca	Gene	20617
24121116	1133	1137	A30P	ProteinMutation	tmVar:p|SUB|A|30|P;HGVS:p.A30P;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893878;CorrespondingSpecies:10090;CA#:257069
24121116	1138	1153	alpha-synuclein	Gene	6622
24121116	1154	1158	mice	Species	10090
24121116	1169	1183	Lewy body-like	Disease	MESH:D020961
24121116	1214	1227	catecholamine	Chemical	MESH:D002395
24121116	1376	1378	DA	Chemical	MESH:D004298
24121116	1448	1457	SNCA-A30P	CellLine	CVCL:YR02
24121116	1458	1462	Snca	Gene	20617
24121116	1466	1470	mice	Species	10090
24121116	1508	1521	catecholamine	Chemical	MESH:D002395
24121116	1523	1537	norepinephrine	Chemical	MESH:D009638
24121116	1600	1609	SNCA-A30P	CellLine	CVCL:YR02
24121116	1610	1614	Snca	Gene	20617
24121116	1618	1622	mice	Species	10090
24121116	1636	1658	behavioral impairments	Disease	MESH:D001523
24121116	1732	1734	PD	Disease	MESH:D010300
24121116	1735	1740	mouse	Species	10090
24121116	1758	1762	A30P	ProteinMutation	tmVar:p|SUB|A|30|P;HGVS:p.A30P;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893878;CorrespondingSpecies:10090;CA#:257069
24121116	1763	1778	alpha-synuclein	Gene	20617
24121116	1897	1899	PD	Disease	MESH:D010300
24121116	Negative_Correlation	MESH:D004298	RS#:104893878;HGVS:p.A30P;CorrespondingGene:6622
24121116	Positive_Correlation	MESH:D010300	RS#:104893878;HGVS:p.A30P;CorrespondingGene:6622
24121116	Association	MESH:D004298	MESH:D010300
24121116	Association	MESH:D015632	6622
24121116	Association	MESH:D004298	MESH:D015632
24121116	Association	MESH:D010300	6622
24121116	Association	20617	21823
24121116	Association	MESH:D004298	20617
24121116	Association	MESH:D004298	6622
24121116	Association	MESH:D010300	6622

